Why Aging People Become DEPRESSED, FATIGUED, and ...
Why Aging People Become DEPRESSED, FATIGUED, and ...
Why Aging People Become DEPRESSED, FATIGUED, and ...
- No tags were found...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
WHY AGING PEOPLE BECOME <strong>DEPRESSED</strong>, <strong>FATIGUED</strong>, AND OVERWEIGHT<br />
49. Steinberg S, Annable L, Young SN, Liyanage N. A placeboconlrolled<br />
clinical trial of L-tr^ptophan in premenstrual dysphoria.<br />
Bini Psychiatry. 1999 Fob 1;45(3):313-20.<br />
50. Hibolicky N, Leiter LA. Anderson GH. Menstiaial cycle eH'ccIs<br />
on the metabolism of ti^vptophan loads. Am J Ciiri Nutr.<br />
1989 Jul;50( 0:46-52.<br />
51. Breum L, Rasmiissen MH, Hilsted J, Femstrom JD. Twenty-fouihoiii'<br />
plasma ti^yptophan concentrations <strong>and</strong> ratios are below<br />
nomial in obese subjects <strong>and</strong> are not normalized by substantial<br />
weight reduction./líí)./C/;» Nulr. 2003 May;77(5):Í 112-8.<br />
52. Wiirtnian, JJ, Wuilman RJ. Suppression of carbollydrate<br />
consuniptiun al snacks und at mealtime by Dl-fenfluramine or<br />
li^yptophan. In S. Garattini &i.K. Samatnin, (Eds.), Ariorectic<br />
agents.-Mechanisjtis of action <strong>and</strong> toierance. New York: Raven Press,<br />
1981:169-82.<br />
53. WuHman JJ, Wuilman RJ, Growdon JH. Heni^y P, Lipscomb A.<br />
Zeisel SH. Carbohydrate craving in obe.se people: Suppre.ssion by<br />
treatments alfecting serotoninergic Iransmission.<br />
hit J Eat Disord. 1981 1(0:2-15.<br />
54. Cavalière H, Medeiros-Neto G. The anorectic effect of increasing<br />
doses of L-ti-yplophan in obese patients. FMt Weight Disiird.<br />
1997Dec;2(4):21l--S.<br />
55. Hcraicf E. Burckhardl P, Wurtman J. Wurtman R. Tiyplophan<br />
administration may enhance weight loss by some moderately<br />
obese patients on a prole in-sparing modified fast (PSMF) diet.<br />
iut J Eat Di.wrd. 1985; 4(3):281-92.<br />
56. Hyman SL, Coyk" JT, Parke JC, et al. Anorexia <strong>and</strong> altered<br />
serotonin metabolism in a patient with argininosuccinic aciduria.<br />
J Pediatr. 1986 May;108(5 Pt l):705-9.<br />
57. Murray MF, Langan M, MacGrcgor RR. Increased plasma<br />
tryptoplian in HIV-infected patients treated with pliaiTnacologic<br />
doses of nicininamide. Nutrition. 2001 Jul:17(7-8):654-6.<br />
58. Chouinard G, Young SN, Annable L. Sourkes TL. Tiyptophannicotinaniide,<br />
imipramine <strong>and</strong> their combination in depression.<br />
A conlrolled studv. .Acta P.'iychiatr Scami. 1979 Apr;59(4):395-4I4.<br />
59. Murray MF. Ti-yptophan depletion <strong>and</strong> HIV infection: a metabolic<br />
link to pathogenesis. Lancet Infect Dis. 2003 Oi;t;3(10):644-52.<br />
60. Lee J. Im VH, Jung HH, et al. Curcumin inhibits interferon-alpha<br />
induced NF-kappaB <strong>and</strong> COX-2 in human A549 non-small cell<br />
lung cancer cells. Biochem Biophvs Res Commun.<br />
2005 Aug 26;334(2):313-8.<br />
6\. Cocipei JR. The ixïle of ascorbic acid in Ihe oxidation of<br />
tr'ypti>pbiin lo 5-hydroxytry plop han. Ann NY Acad Sei.<br />
1961 Apr21;92:2Ó8-ll.<br />
62. Freyre AV, Flichman JC. Spasniophilia caused by magnesium<br />
deficit. Psychosomatics. 1970 Sep;t U5):5OO-1.<br />
63. Schneider-Helmert D, Splnwebei CL. Evaluation of L-lryptophan<br />
foi" treatment of insomnia: a iïview. Psychopliarmacology (Berl).<br />
I986;89(l):l-7.<br />
64. Ferrero F, Zahnd J. Tryptophan in the tœatment of insomnia in<br />
hospitalized psychiatric palients. Encéphale. 1987 JLin:!3( I ):35-7.<br />
65. No aulhors listed. Monograph: L-Tr'yplophan. Altem Med Rev.<br />
2006Mar;ll(l):52-6.<br />
66. Young SN, Oravee M. The effect ol growth honnttne
Change language